Romosozumab or Alendronate for Fracture Prevention in East Asian Patients: A Subanalysis of the Phase III, Randomized ARCH Study

Osteoporosis International - United Kingdom
doi 10.1007/s00198-020-05324-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search